Labcorp Holdings Files 8-K: Regulation FD & Exhibits
Ticker: LH · Form: 8-K · Filed: 2024-10-10T00:00:00.000Z
Sentiment: neutral
Topics: 8-k, disclosure, regulatory
Related Tickers: LH
TL;DR
Labcorp filed an 8-K. Standard reporting stuff.
AI Summary
On October 9, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it confirms the company's ongoing reporting obligations.
Why It Matters
This filing indicates Labcorp Holdings is fulfilling its regulatory reporting requirements with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 0000920148-24-000111 (filing_id) — Accession Number
- October 9, 2024 (date) — Date of earliest event reported
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for LABCORP HOLDINGS INC.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is October 9, 2024.
Where are LABCORP HOLDINGS INC.'s principal executive offices located?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the Commission File Number for LABCORP HOLDINGS INC.?
The Commission File Number is 1-11353.
What is the IRS Employer Identification Number for LABCORP HOLDINGS INC.?
The IRS Employer Identification Number is 99-2588107.
From the Filing
0000920148-24-000111.txt : 20241010 0000920148-24-000111.hdr.sgml : 20241010 20241010065848 ACCESSION NUMBER: 0000920148-24-000111 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241009 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241010 DATE AS OF CHANGE: 20241010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241363799 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20241009.htm 8-K lh-20241009 October 9, 2024 0000920148 false 0000920148 2024-10-09 2024-10-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 9, 2024 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock , $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure On October 10, 2024, Labcorp Holdings Inc. announced that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The d